<DOC>
	<DOCNO>NCT00828958</DOCNO>
	<brief_summary>The purpose study examine discontinuation rate schizophrenia patient receive multiple sequential 2 mL injection long act injectable risperidone ( atypical antipsychotic medication ) administer deltoid muscle every 2 week .</brief_summary>
	<brief_title>Injection Site Tolerability Multiple Dose Treatment With Long-acting Injectable Risperidone Administered Via Deltoid Muscle Chronic Schizophrenia Patients .</brief_title>
	<detailed_description>This open-label , multiple-dose , multicenter study chronic schizophrenia patient , receive long-acting injectable risperidone 25 37.5-mg injection gluteal muscle , clinically require high dose . The study consist pretreatment screen phase , 8-week , open label treatment phase patient receive 4 sequential 2 mL injection long-acting injectable risperidone ( 37.5 50 mg ) administer every 2 week deltoid muscle alternate arm ( right versus leave ) visit ; post treatment phase consist end study evaluation upon completion study procedure Day 57 early withdrawal . The study hypothesis repeat injection long-acting injectable risperidone deltoid muscle safe well tolerate assessed percent patient discontinue least 2 injection . Safety assess use adverse event ( include occurrence extrapyramidal symptom assess Extrapyramidal Symptoms Rating Scale ) , clinical laboratory test ( hematology , serum chemistry , urinalysis , pregnancy test ) , vital sign , physical examination , electrocardiogram , injection site evaluation . The patient receive 4 injection long-acting injectable risperidone ( 37.5 50 mg ) administer 1 injection every 2 week deltoid muscle .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<criteria>Chronic schizophrenia subtype , accord DSMIV criterion current treatment longacting injectable risperidone 25 mg 37.5 mg gluteal injection adequate study least 2 injection , need dose increase longacting injectable risperidone clinical reason inform consent sign patient patient otherwise healthy basis prestudy physical examination medical history . No DSM IV Axis I diagnosis schizophrenia pregnant breast feed woman female subject childbearing potential without adequate contraception history severe drug allergy hypersensitivity patient inadequate mass deltoid region receive intramuscular drug injection .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>schizophrenia</keyword>
	<keyword>Risperidone</keyword>
	<keyword>Long act injectable</keyword>
	<keyword>Intradeltoidal injection</keyword>
</DOC>